• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • DMF (Drug Master Filing) – Pharmaceutical Products
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • CML (China Manufacture Licence) – Pressure vessels
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Company Profile
    • Partners
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Information
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • DMF
      • CCC
      • Pressure Vessels
    • Publications
    • Brochure
    • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Health Food
  • Registration of Infant Formula in China

Registration of Infant Formula in China

Thursday, 01 June 2017 / Published in Health Food, News

Registration of Infant Formula in China

Registration of Infant Formula in China is booming.

As already reported in December last year, the NMPA issued the rules for registration of infant formula on 8.6.2016, and on 22.11.2016 the new online-platform for the registration of infant formula was launched. Until01.01.2018 Chinese as well as foreign manufacturers of infant formula must get their registration certificate, otherwise their products cannot be imported or traded in China. Ever since CCAP has had an enormous increase in applications for registration of infant formula, up to now more than 60 manufacturers have applied for registration of 213 products.

NMPA announcement No. 2017-65 of 25.5.2017 (Application Documents and their Requirements for Infant Formula Registration) simplified the application for registration, in order to make sure that the first applicants get their certificates before the deadline on 01.01.2018.

If you have further questions in regard to above mentioned topic, please do not hesitate to contact us:

Cisema GmbH
Tel.: +49 89 4161 7389 – 00
Fax: +49 89 7484 9956
info@cisema.de
www.cisema.de

Tagged under: Infant Formula, NMPA

What you can read next

Extensive Update of the Implementation Rules for the CCC Certification of Automotive Parts
Cisema Webinar with CBBC: Opportunities and Regulatory Implications Associated with the Rise of China’s Digital Economy in Healthcare
NMPA updates safety standards for cosmetic ingredients

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Drug Master Filing
      • Health Food
      • Medical Device
    • RoHS
  • Publications
  • Seminars
  • Webinars

Recent Posts

  • Updates on the Medical Device Classification Catalogue in China

    On December 31, 2020, the NMPA announced (No.14...
  • Cisema Partners with Advamed

    Cisema is delighted to announce it is now an as...
  • Guidelines for Sampling Testing on Organic Foods

    On December 4, 2020, the CNCA (Certification an...
  • Draft of Prohibited List and Existing List of Cosmetic Ingredients Announced

    On January 22, 2021, the NIFDC (China National ...
  • Guideline and Standard Update for Medical Devices & IVDs in January and February 2021

    China Regulatory Guidelines Issued / Updated Th...

Archive

Cisema

With nine locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Events
  • News & Information
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2019 Cisema. All rights reserved.

TOP